WallStreetZenWallStreetZen

NASDAQ: CLRB
Cellectar Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CLRB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$38.0M
Current Profit Margin
0%

CLRB Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when CLRB announces earnings.

CLRB Return on Assets

Current Company
-276.4%
Current Industry
2.9%
CLRB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CLRB Return on Capital Employed

Current Company
4,413.17%
Current Industry
19.5%
CLRB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLRB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CLRB$0.00-$37.79M-$37.98MN/AN/A
BRNS$802.00k-$69.64M-$73.35M-41.49%N/A
VANI$0.00-$24.39M-$25.65M-100.00%N/A
CLSD$8.23M-$32.42M-$32.49M+207.34%N/A
ANIX$210.00k-$10.70M-$10.74M-28.36%N/A
View Top Biotech Stocks

CLRB earnings dates

Next earnings date
May 2, 2024

Cellectar Biosciences Earnings & Revenue FAQ

What were CLRB's earnings last quarter?

On Invalid Date, Cellectar Biosciences (NASDAQ: CLRB) reported Q4 2023 earnings per share (EPS) of -$0.40, up 27.27% year over year. Total Cellectar Biosciences earnings for the quarter were -$7.45 million. In the same quarter last year, Cellectar Biosciences's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Cellectar Biosciences stock.

What was CLRB's earnings growth in the past year?

As of Q2 2024, Cellectar Biosciences's earnings has grown year over year. Cellectar Biosciences's earnings in the past year totalled -$37.98 million.

What is CLRB's earnings date?

Cellectar Biosciences's earnings date is Invalid Date. Add CLRB to your watchlist to be reminded of CLRB's next earnings announcement.

What was CLRB's revenue last quarter?

On Invalid Date, Cellectar Biosciences (NASDAQ: CLRB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cellectar Biosciences's revenue was $0.00.

What was CLRB's revenue growth in the past year?

As of Q2 2024, Cellectar Biosciences's revenue has grown null year over year. Cellectar Biosciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.